CAS 59086-90-7|Ingenol 3,20-dibenzoate

Introduction:Basic information about CAS 59086-90-7|Ingenol 3,20-dibenzoate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameIngenol 3,20-dibenzoate
CAS Number59086-90-7Molecular Weight556.64500
Density1.32 g/cm3Boiling Point697ºC at 760 mmHg
Molecular FormulaC34H36O7Melting Point/
MSDS/Flash Point221.6ºC

Names

Nameingenol 3,20-dibenzoate
SynonymMore Synonyms

Ingenol 3,20-dibenzoate BiologicalActivity

DescriptionIngenol 3,20-dibenzoate is a potent protein kinase C (PKC) isoform-selective agonist. Ingenol 3,20-dibenzoate induces selective translocation of nPKC-delta, -epsilon, and -theta and PKC-mu from the cytosolic fraction to the particulate fraction and induces morphologically typical apoptosis through de novo synthesis of macromolecules. Ingenol 3,20-dibenzoate increases the IFN-γ production and degranulation by NK cells, especially when NK cells are stimulated by NSCLC cells[1][2].
Related CatalogSignaling Pathways >>Epigenetics >>PKCResearch Areas >>Inflammation/ImmunologySignaling Pathways >>TGF-beta/Smad >>PKC
In VitroIngenol 3,20-dibenzoate (0-10000 nM; 4 hours) enhanced NK cells (stimulated by A549 cells and H1299 cells) degranulation[2]. Ingenol 3,20-dibenzoate (0.001-10 μg/ml) dose dependently promoted UT-7/EPO cell proliferation with an EC50 of 0.27 μg/ml (485 nM)[3].
In VivoIngenol 3,20-dibenzoate (20 μg/mouse; i.p.; on days 3, 7, and 11) lessens the anemia induced by 5-fluorouracil in an in vivo mouse model[3]. Animal Model: Male C57BL/6 mice (8–12 weeks old)[3] Dosage: 20 μg/mouse Administration: I.p.; On days 3, 7, and 11 Result: Severity of 5-FU–induced anemia was lessened by IDB treatment on days 12 and 20.
References

[1]. Asada A, et al. Induction of thymocyte apoptosis by Ca2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation. J Biol Chem. 1998;273(43):28392-28398.

[2]. Gong C, et al. Enhancement of NK cell-mediated lysis of non-small lung cancer cells by nPKC activator, ingenol 3,20 dibenzoate. Mol Immunol. 2017;83:23-32.

[3]. Oh JG, et al. Biphasic Effects of Ingenol 3,20-Dibenzoate on the Erythropoietin Receptor: Synergism at Low Doses and Antagonism at High Doses. Mol Pharmacol. 2015;88(2):392-400.

Chemical & Physical Properties

Density1.32 g/cm3
Boiling Point697ºC at 760 mmHg
Molecular FormulaC34H36O7
Molecular Weight556.64500
Flash Point221.6ºC
Exact Mass556.24600
PSA110.13000
LogP4.54460
Index of Refraction1.639
InChIKeyGIMKEHNOTHXONN-HNIMUKOUSA-N
SMILESCC1=CC23C(=O)C(C=C(COC(=O)c4ccccc4)C(O)C2(O)C1OC(=O)c1ccccc1)C1C(CC3C)C1(C)C

Safety Information

Hazard CodesXn: Harmful;
Risk PhrasesR20/21/22
Safety Phrases26-36

Synonyms

ingenoldibenzoate
CAS 1215518-24-3|N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)-N-(2-morpholinoethyl)thiophene-2-carboxa
CAS 1216786-82-1|4-cyano-N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)-N-(2-morpholinoethyl)benzamide h
Recommended......
TOP